Results 151 to 160 of about 136,281 (235)

Staphylococcus aureus Augments Epithelial Skin Barrier Damage Through T Cell Activation in Cutaneous T Cell Lymphoma

Allergy, EarlyView.
Staphylococcus aureus, commonly colonising CTCL patients, augments skin barrier dysfunction. Staphylococcal enterotoxins induce T‐cell release of barrier‐repressing cytokines (IL‐4, IL‐13, IL‐22, OSM). Cytokine signalling drives JAK‐dependent downregulation of filaggrin and loricrin in keratinocytes. Antibiotic‐mediated eradication of S. aureus induces
Maria Gluud, Emil M. Pallesen, Ziao Zeng, Martin R. J. Namini, Chella Krishna Vadivel, Lise Mette Rahbek Gjerdrum, Lang Yan, Sana Ahmad, Lise M. Lindahl, Michael Bzorek, Maria R. Kamstrup, Saptaswa Dey, Sisse Rye Ostrowski, Erik Sørensen, Pia Rantakari, Charlotte Menne Bonefeld, Carsten Geisler, Anders Woetmann, Riitta Lahesmaa, Lars Iversen, Peter Wolf, Thomas Litman, Terkild B. Buus, Niels Ødum   +23 more
wiley   +1 more source

Skin Barrier Dysfunction in Contact and Atopic Dermatitis: A Comparative Review. [PDF]

Allergy Asthma Immunol Res
Maeng J, Jeong S, Kim H.
europepmc   +1 more source

Non‐Invasive Scalp Tape‐Strip RNA Sequencing Captures Disease Activity and Treatment‐Response Signatures in Alopecia Areata

Allergy, EarlyView.
Non‐invasive scalp tape‐strip RNA sequencing captures core immune and follicular molecular signatures in alopecia areata. Tape‐strip transcriptomic profiles reflect disease severity and treatment response to baricitinib, with concordance to scalp biopsy‐derived signatures.
Carmen Mochón‐Jiménez, Jesús Gay‐Mimbrera, Viviana Dávila‐Flores, Helen He, Jerry Zhou, Irene Rivera‐Ruiz, Pedro J. Gómez‐Arias, Juan de Luque‐Fernández, Benjamin Ungar, Emma Guttman‐Yassky, Juan Ruano   +10 more
wiley   +1 more source

Predicting Role of Interleukin-33 in Determining the Development and Severity of Atopic Dermatitis. [PDF]

Immun Inflamm Dis
Ghasemiyeh AR, Arani MH, Riazian F, Aghajani A, Azadchehr MJ, Motedayyen H.   +5 more
europepmc   +1 more source

The Role of the Cysteamine Dioxygenase (ADO) Gene in Atopic Dermatitis. [PDF]

Acta Derm Venereol
Wang S, Vaz R, Lysell J, Eisfeldt J, Sahlén P, Asad S, Wahlgren CF, Nordenskjöld M, Bradley M, Tapia-Paez I.   +9 more
europepmc   +1 more source

Interleukin‐22 and Interleukin‐18 as Potential Blood Biomarkers in Dupilumab‐Treated Atopic Dermatitis

Allergy, EarlyView.
Ayano Fukushima‐Nomura, Hiroshi Kawasaki, Takehiro Hasegawa, Erika Yanagisawa, Keiji Tanese, Nozomi Yanagida, Shoko Obata, Kiyoshi Yashiro, Yoshihiro Ito, Haruhiko Koseki, Masayuki Amagai   +10 more
wiley   +1 more source

Predictors of Patient Satisfaction in Atopic Dermatitis.

Acta Derm Venereol
Halioua B, Taieb C, Merhand S, Staumont-Salle D.   +3 more
europepmc   +1 more source

Clinically Meaningful Improvement in Atopic Dermatitis According to Treatment Type in a Real- World Cohort. [PDF]

Acta Derm Venereol
Chew Bonilla E, Vega-Del Pilar YX, Vilchis Chaparro E, Lemini López A.   +3 more
europepmc   +1 more source

Early Epidemiologic and Immune Predictors of Atopic Dermatitis: Reduced Cord Blood Regulatory B10 Cells in the Munich Atopy Prediction Study (MAPS)

Allergy, EarlyView.
In this prospective birth cohort from Munich, comprehensive clinical assessments and longitudinal lifestyle questionnaires were combined with cord blood immune profiling. Infants who later developed AD showed altered cord blood immune signatures, including reduced CD4+ T cells, increased B cells and markedly decreased Breg cells. Epidemiologic factors,
S. Preis, S. Kaesler, M. Koeberle, M. Hils, B. Evers, R. L. Silva, Y. Skabytska, L. Schellenberger, H. Hufnagel, M. Schielein, B. Kuschel, Y. Amar, A. Zink, T. Biedermann, Z. Kurgyis   +14 more
wiley   +1 more source